|
|
|
|
| LEADER |
01336 am a22002053u 4500 |
| 001 |
121236 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Vunjak-Novakovic, Gordana V
|e author
|
| 100 |
1 |
0 |
|a Harvard University-
|e contributor
|
| 700 |
1 |
0 |
|a Bhatia, Sangeeta N
|e author
|
| 700 |
1 |
0 |
|a Chen, Christopher
|e author
|
| 700 |
1 |
0 |
|a Hirschi, Karen
|e author
|
| 245 |
0 |
0 |
|a HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease
|
| 260 |
|
|
|b Biomed Central Ltd.,
|c 2019-06-10T19:00:57Z.
|
| 856 |
|
|
|z Get fulltext
|u https://hdl.handle.net/1721.1/121236
|
| 520 |
|
|
|a Our project team is developing an integrated microphysiological platform with functionally connected vascular, liver and cardiac microtissues derived from a single line of human pluripotent stem cells. The platform enables functional representation of human physiology in conjunction with real-time biological readouts (via imaging and homologous reporters for all three cell phenotypes) and compatibility with high-throughput/high-content analysis. In this paper, we summarize progress made over the first year of the grant. Keywords: Vioxx, Glycol Diacrylate, Genotype Pool, Tissue Module, Polyethylene Glycol Diacrylate
|
| 520 |
|
|
|a National Institutes of Health (U.S.) (Grant UH2 EB017103)
|
| 546 |
|
|
|a en
|
| 655 |
7 |
|
|a Article
|
| 773 |
|
|
|t Stem Cell Research & Therapy
|
